imatinib mesylate has been researched along with Arthritis, Gouty in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balbino, B; Contag, CH; Galli, SJ; Gaudenzio, N; Kang, D; Raghu, H; Reber, LL; Robinson, WH; Rogalla, S; Sensarn, S; Sibilano, R; Sokolove, J; Starkl, P; Tsai, M | 1 |
1 other study(ies) available for imatinib mesylate and Arthritis, Gouty
| Article | Year |
|---|---|
The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice.
Topics: Animals; Arthritis, Gouty; Crystallization; Imatinib Mesylate; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Uric Acid | 2017 |